抗腫瘍性の
ホルモン抗悪性腫瘍
代謝拮抗剤、抗悪性腫瘍
抗腫瘍性抗生物質
抗腫瘍アジュバント
他の抗悪性腫瘍薬
抗悪性腫瘍の天然の供給源
アルキル化抗悪性腫瘍
イマチニブの抗悪性腫瘍
特発性肺線維症(IPF)治療
抗腫瘍薬は体内の腫瘍細胞に対して抑制と殺滅作用を備える薬物である。腫瘍の総合的な治療中で重要な位置を占め,特に外科手術によって治療できない白血病、播種性腫瘍の治療に非常に重要である。現在使用している抗腫瘍薬の多くは、DNA又はRNAの合成を抑制し、さらにDNA構造を破壊することによってその役割を果たす。各期間の腫瘍細胞への影響により,細胞周期特異性薬と細胞周期非特異性薬という二つの種類に分けられる。このような二つの種類の薬物は異なるが,骨髄の造血幹細胞及び他の成長周期が短い細胞に対していずれも一定の殺傷作用を備え,且つ生体防御反応を抑制することができる。抗腫瘍薬は種類が多く,以下の種類に分けられることができる:アルキル化剤類,例えばシクロホスファミド、グリシンホスホラミド、チオテパ等;代謝拮抗薬,例えばメトトレキセート、メルカプトプリン、5-フルオロウラシル、ヒドロキシウレア等;抗生物質類,例えばダクチノマイシン、マイトマイシンC、ブレオマイシン等;ホルモン等,例えばプレドニゾン、プロピオン酸テストステロン、ジエチルスチルベストロール等;あるボタニカルズ,例えばビンブラスチン、カンプトテシン、コルヒチン等;その他の種類,例えばプロカルバジン塩酸塩、レゾキサン、エチルジモルホリン等。抗腫瘍薬は非常に多いが、それらの作用機構が異なるため,臨床応用の場合に慎重に選択する必要がある。
- Structure:

- Chemical Name:サゴピロン
- CAS:305841-29-6
- MF:C30H41NO6S
- Chemical Name:モガムリズマブ(遺伝子組換え)
- CAS:1159266-37-1
- MF:
- Chemical Name:Amatuximab
- CAS:931402-35-6
- MF:
- Structure:

- Chemical Name:オンブラブリン塩酸塩
- CAS:253426-24-3
- MF:C21H26N2O6.ClH
- Structure:

- Chemical Name:セブリプラチン
- CAS:110172-45-7
- MF:C6H6O4Pt.C5H14N2
- Structure:

- Chemical Name:アムバチニブ塩酸塩
- CAS:1055986-67-8
- MF:C23H22ClN5O3S
- Chemical Name:Carlumab
- CAS:915404-94-3
- MF:
- Structure:

- Chemical Name:クロリブリン
- CAS:1000852-17-4
- MF:C18H17BrN4O3
- Chemical Name:Drozitumab
- CAS:912628-39-8
- MF:
- Chemical Name:Emepepimut-S (ACI)
- CAS:1225284-76-3
- MF:
- Chemical Name:Enavatuzumab
- CAS:1062149-33-0
- MF:
- Chemical Name:Ensituximab
- CAS:1092658-06-4
- MF:
- Chemical Name:Immunoglobulin, anti-(human glycoprotein NMB extracellular domain) (human monoclonal CR011 heavy chain), disulfide with human monoclonal CR011 κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]car...
- CAS:1182215-65-1
- MF:
- Structure:

- Chemical Name:BA 100
- CAS:1214283-52-9
- MF:C21H25FIN3O3
- Structure:

- Chemical Name:イロススタット
- CAS:288628-05-7
- MF:C14H15NO5S
- Chemical Name:Icrucumab
- CAS:1024603-92-6
- MF:
- Chemical Name:Lorvotuzumab Mertansine
- CAS:1008106-64-6
- MF:
- Structure:

- Chemical Name:Navitoclax dihydrochloride
- CAS:1093851-28-5
- MF:C47H55ClF3N5O6S3. 2HCl
- Structure:

- Chemical Name:レシリシブ
- CAS:334969-03-8
- MF:C16H13ClO4S
- Structure:

- Chemical Name:ベルブリン
- CAS:827031-83-4
- MF:C17H17N3O
- Structure:

- Chemical Name:ティボザニブ塩酸塩水和物
- CAS:682745-41-1
- MF:C22H22Cl2N4O6
- Structure:

- Chemical Name:アルドキソルビシン
- CAS:1361644-26-9
- MF:C37H42N4O13
- Structure:

- Chemical Name:Nelipepimut-S
- CAS:160212-35-1
- MF:C50H78N10O11
- Structure:

- Chemical Name:パリホスファミドトロメタミン
- CAS:1070409-31-2
- MF:C8H22Cl2N3O5P
- Structure:

- Chemical Name:レシリシブナトリウム
- CAS:922139-31-9
- MF:C16H12ClNaO4S
- Chemical Name:Flanvotumab
- CAS:1188277-05-5
- MF:
- Chemical Name:Vorsetuzumab Mafodotin
- CAS:1165741-01-4
- MF:
- Structure:

- Chemical Name:サリデギブ
- CAS:1037210-93-7
- MF:C29H48N2O3S
- Structure:

- Chemical Name:アベキシノスタット塩酸塩
- CAS:783356-67-2
- MF:C21H24ClN3O5
- Structure:

- Chemical Name:エルパモチド
- CAS:673478-49-4
- MF:C47H76N16O13
- Structure:

- Chemical Name:パノビノスタット乳酸塩
- CAS:960055-68-9
- MF:C24H29N3O5
- Structure:

- Chemical Name:アルドキソルビシン塩酸塩
- CAS:1361563-03-2
- MF:C37H43ClN4O13
- Chemical Name:オナルツズマブ(遺伝子組換え)
- CAS:1133766-06-9
- MF:
- Structure:

- Chemical Name:IPI-926塩酸塩
- CAS:1169829-40-6
- MF:C29H49ClN2O3S
- Chemical Name:ネシツムマブ(遺伝子組換え)
- CAS:906805-06-9
- MF:
- Chemical Name:Samalizumab
- CAS:1073059-33-2
- MF:
- Chemical Name:タバルマブ(遺伝子組換え)
- CAS:1143503-67-6
- MF:
- Chemical Name:Narnatumab
- CAS:1188275-92-4
- MF:
- Chemical Name:Demcizumab
- CAS:1243262-17-0
- MF:
- Structure:

- Chemical Name:ベルブリン塩酸塩
- CAS:917369-31-4
- MF:C17H17N3O.HCl
- Structure:

- Chemical Name:Pegdinetanib
- CAS:906450-24-6
- MF:C27H46N6O13S
- Chemical Name:Entolimod
- CAS:951628-22-1
- MF:
- Chemical Name:Calaspargase pegol
- CAS:941577-06-6
- MF:
- Chemical Name:Trabedersen
- CAS:925681-61-4
- MF:
- Structure:

- Chemical Name:ボラセルチブ塩酸塩
- CAS:946161-17-7
- MF:C34H51ClN8O3
- Chemical Name:Ficlatuzumab
- CAS:1174900-84-5
- MF:
- Structure:

- Chemical Name:Poly(oxy-1,2-ethanediyl), α-hydro-ω-[2-[[2-[[(4S)-9-[([1,4′-bipiperidin]-1′-ylcarbonyl)oxy]-4,11-diethyl-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-4-yl]oxy]-2-oxoethyl]amino]-2-oxoethoxy]-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1)
- CAS:848779-32-8
- MF:(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nC153H176N20O36
- Structure:

- Chemical Name:クレノラニブベシル酸塩
- CAS:670220-93-6
- MF:C32H35N5O5S
- Chemical Name:Dalantercept
- CAS:1186210-24-1
- MF:
- Chemical Name:オララツマブ(遺伝子組換え)
- CAS:1024603-93-7
- MF:
- Chemical Name:Vorsetuzumab
- CAS:1165740-62-4
- MF:
- Chemical Name:トレバナニブ(遺伝子組換え)
- CAS:894356-79-7
- MF:
- Structure:

- Chemical Name:キシノスタット塩酸塩
- CAS:1083078-98-1
- MF:C21H27ClN6O2
- Structure:

- Chemical Name:Alisertib sodium
- CAS:1208255-63-3
- MF:C27H19ClFN4O4. Na. H2O
- Structure:

- Chemical Name:Gusacitinib
- CAS:1425381-60-7
- MF:C24H28N8O2
- Structure:

- Chemical Name:1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-, hydrate (1:)
- CAS:1386861-49-9
- MF:C22H19ClN6O2
- Chemical Name:Research Grade Ipafricept (DHK29201)
- CAS:1391727-24-4
- MF:
- Structure:

- Chemical Name:イロラセルチブ
- CAS:1227939-82-3
- MF:C25H21FN6O2S
- Chemical Name:MGA271
- CAS:1353485-38-7
- MF:
- Structure:

- Chemical Name:PSMA-617
- CAS:1702967-37-0
- MF:C49H71N9O16
- Chemical Name:イネビリズマブ(遺伝子組換え)
- CAS:1299440-37-1
- MF:
- Structure:

- Chemical Name:Benzenesulfonamide, 2-[[5-chloro-2-[[4-[(4-methyl-1-piperazinyl)methyl]phenyl]amino]-4-pyrimidinyl]amino]-N,N-dimethyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:2)
- CAS:2305089-34-1
- MF:C28H36ClN7O8S
- Structure:

- Chemical Name:レバスチニブトシル酸塩
- CAS:1033893-29-6
- MF:CH6ClNO
- Chemical Name:Lirilumab
- CAS:1000676-41-4
- MF:
- Chemical Name:Ascrinvacumab
- CAS:1463459-96-2
- MF:
- Chemical Name:Research Grade Eftozanermin Alfa (DHA29113)
- CAS:1820660-69-2
- MF:
- Structure:

- Chemical Name:ゴルバチニブ酒石酸塩
- CAS:1007601-96-8
- MF:C37H43F2N7O10
- Structure:

- Chemical Name:ピラルビシン塩酸塩
- CAS:95343-20-7
- MF:C32H38ClNO12
- Structure:

- Chemical Name:エチリノテカンペゴル四塩酸塩
- CAS:1193151-09-5
- MF:(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nC153H176N20O36.4ClH
- Chemical Name:Pidilizumab
- CAS:1036730-42-3
- MF:
- Structure:

- Chemical Name:フォリチキソリンカルシウム
- CAS:133978-75-3
- MF:C20H25CaN7O6
- Structure:

- Chemical Name:トラセニブリン酸塩
- CAS:874819-74-6
- MF:C22H28FN4O6P
- Structure:

- Chemical Name:ダリナパルシン
- CAS:69819-86-9
- MF:C12H22AsN3O6S
- Structure:

- Chemical Name:塩化ラジウム (223Ra)
- CAS:444811-40-9
- MF:Cl2Ra
- Structure:

- Chemical Name:EC-18 221139-79-3
- CAS:221139-79-3
- MF:C39H70O6
- Structure:

- Chemical Name:Cevipabulin succinate
- CAS:852954-81-5
- MF:C22H24ClF5N6O5
- Chemical Name:Agatolimod sodium
- CAS:541547-35-7
- MF:
- Structure:

- Chemical Name:ASN-002_Hydrochloride
- CAS:2228989-14-6
- MF:C24H29ClN8O2
- Chemical Name:腫瘍壊死因子-Α
- CAS:94948-59-1
- MF:NULL
- Chemical Name:Imgatuzumab
- CAS:959963-46-3
- MF:
- Structure:

- Chemical Name:Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-, (2Z)-2-butenedioate (1:1)
- CAS:2242394-65-4
- MF:C26H23N7O2.C4H4O4
- Chemical Name:Cintredekin besudotox
- CAS:372075-36-0
- MF:
- Structure:

- Chemical Name:イメキソン
- CAS:59643-91-3
- MF:C4H5N3O
- Structure:

- Chemical Name:ピマセルチブ塩酸塩
- CAS:1236361-78-6
- MF:C15H16ClFIN3O3
- Chemical Name:Tovetumab
- CAS:1243266-04-7
- MF:
- Chemical Name:Research Grade Inbakicept (DHE28302)
- CAS:2135939-52-3
- MF:
- Structure:

- Chemical Name:2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-, hydrochloride (1:1)
- CAS:1874231-60-3
- MF:C26H25ClF3N7O3S
- Chemical Name:Bempegaldesleukin
- CAS:1939126-74-5
- MF:
- Structure:

- Chemical Name:ビンタフォリド
- CAS:742092-03-1
- MF:C86H109N21O26S2
- Structure:

- Chemical Name:KX2-391 (Mesylate)
- CAS:1080645-95-9
- MF:C27H33N3O6S
- Structure:

- Chemical Name:Etirinotecan pegol tetratriflutate
- CAS:1193151-12-0
- MF:(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nC153H176N20O36.4C2HF3O2
- Structure:

- Chemical Name:Berubicin hydrochloride
- CAS:293736-67-1
- MF:C34H35NO11. HCl
- Structure:

- Chemical Name:(2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide Hydrochloride
- CAS:1385020-40-5
- MF:C20H23ClF2N4O2S
- Chemical Name:Vesencumab
- CAS:1205533-60-3
- MF:
- Chemical Name:Duligotuzumab
- CAS:1314238-96-4
- MF:
- Chemical Name:Vantictumab
- CAS:1345009-45-1
- MF:
- Structure:

- Chemical Name:フィルテカンペゴル
- CAS:946062-05-1
- MF:(C2H4O)n(C2H4O)n(C2H4O)n(C2H4O)nC110H106N12O33
- Chemical Name:Cantuzumab Ravtansine
- CAS:868747-45-9
- MF:
- Chemical Name:Dilpacimab
- CAS:1791420-09-1
- MF:
- Structure:

- Chemical Name:2-Propenoic acid, 3-[4-[[2-(4-fluoro-2,6-dimethylbenzoyl)-6-hydroxybenzo[b]thien-3-yl]oxy]phenyl]-, (2E)-
- CAS:2088518-51-6
- MF:C26H19FO5S